TopFunds

Danaher Corp

NYSE: DHR

Stock price

229.04 USD

(+0%) TODAY

healthcareMedical - Diagnostics & Research
Financials

all figures in US$ Millions except per share data

Sections:

Periods:

View:

Format:

Actual
10 year cagr
Help
Where available up to 10y CAGR shown for absolute numbers 10y Average marked A shown for relative numbers such as margins
Fiscal
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Average (A)
Fiscal period end dates
Expand all rows
01Earnings per share
Help
Earnings per share = Net Income / Number of Shares Outstanding
4.7
3.7
3.5
3.7
3.4
4.9
8.6
9.6
6.4
5.3
5
0.6%
02Free cash flow per share
4.6
4.2
4.1
4.8
4.6
7.5
9.6
10
7.8
7.2
7.4
4.8%
03Dividends per share
0.5
25
0.5
0.6
0.6
0.6
0.7
0.9
1
1.1
1.3
9.9%
04Dividends payout, %
13.6%
15.7%
15.2%
16.4%
20.6%
16.9%
11.5%
11.4%
17.2%
19.7%
24.3%
6%
PROFIT AND LOSS STATEMENT
05Revenue
14,434
16,882
18,330
17,049
17,911
22,284
29,453
26,643
23,890
23,875
24,568
5.5%
06% Change
-
-
-
-
-
-
-
-
-
-
-
5.5%
07Cost of revenue
(6,520)
(7,499)
(8,099)
(7,543)
(7,927)
(9,809)
(11,501)
(10,455)
(9,856)
(9,669)
(9,598)
3.9%
08Gross profit
7,914
9,383
10,231
9,505
9,984
12,475
17,952
16,188
14,034
14,206
14,970
6.6%
09% Margin
54.8%
55.6%
55.8%
55.8%
55.7%
56%
61%
60.8%
58.7%
59.5%
60.9%
57.7% A
10Operating expenses
(5,496)
(6,396)
(7,081)
(6,435)
(6,621)
(8,163)
(9,902)
(8,652)
(8,755)
(9,022)
(9,833)
6%
11% of Revenue
(38.1)%
(37.9)%
(38.6)%
(37.8)%
(37)%
(36.6)%
(33.6)%
(32.5)%
(36.7)%
(37.8)%
(40)%
(37)% A
12Operating Income
2,418
2,987
3,150
3,070
3,362
4,312
8,050
7,536
5,279
5,184
5,137
7.8%
13Income tax expense
(292.7)
(457.9)
(469)
(555.6)
(873)
(849)
(1,251)
(818)
(823)
(747)
(619)
7.8%
14Net Income
2,597
2,554
2,492
2,651
2,557
3,646
6,433
7,209
4,764
3,899
3,614
3.4%
15% Margin
18%
15.1%
13.6%
15.6%
14.3%
16.4%
21.8%
27.1%
19.9%
16.3%
14.7%
17.5% A
16Shares Outstanding
708.5
699.8
706.1
710.2
725.5
718.7
736.8
737.1
743.1
737.2
711
-
17EPS Basic
4.8
3.7
3.6
3.8
3.5
5
8.8
9.8
6.4
5.3
5.1
0.5%
18EPS Diluted
4.7
3.7
3.5
3.7
3.4
4.9
8.6
9.6
6.4
5.3
5
0.6%
19EBITDA
3,060
3,924
4,340
4,277
4,603
6,543
10,007
9,485
7,499
7,276
6,945
8.5%
% Margin
21.2%
23.2%
23.7%
25.1%
25.7%
29.4%
34%
35.6%
31.4%
30.5%
28.3%
28% A
20Net Interest Income (expense)
(135.2)
(184.2)
(155.2)
(127.7)
30.4
(202)
(230)
(166)
14
(161)
(235)
5.7%
21Net Debt / EBITDA
3.9
2.9
2.3
2.1
0.6
2.5
2.1
1.5
1.8
2.1
2
2.2 A
BALANCE SHEET
ASSETS
Current Assets
22Cash & equivalents
790.8
963.7
630.3
787.8
19,912
6,035
2,586
5,995
5,864
2,078
4,615
19.3%
23Short-term investments
-
-
-
-
-
-
-
-
-
-
-
-
24Accounts receivable
2,985
3,186
3,522
3,112
3,268
4,810
5,443
5,064
4,637
4,390
3,913
2.7%
25Other current assets
2,488
805.9
857.1
1,563
787.6
665
852
2,059
842
699
1,739
(3.5)%
26Inventory
1,573
1,709
1,841
1,631
1,628
2,292
2,767
2,765
2,594
2,330
2,489
4.7%
27Total Current Assets
7,837
6,665
6,850
7,094
25,597
13,802
11,648
15,883
13,937
9,497
12,756
5%
Non-Current Assets
28Net property, plant & equipment
2,303
2,354
2,455
2,250
3,066
4,204
4,831
4,593
5,605
6,074
6,745
11.4%
29Long-term investments
401.4
170.1
45.4
38.3
33.7
27
1,320
2,164
1,696
1,815
1,550
14.5%
30Other non-current assets
37,681
36,106
37,299
38,451
33,386
58,128
65,385
61,710
63,250
60,156
62,413
5.2%
31Total Non-Current Assets
40,386
38,630
39,799
40,739
36,485
62,359
71,536
68,467
70,551
68,045
70,708
5.8%
Total Assets
48,222
45,295
46,649
47,833
62,082
76,161
83,184
84,350
84,488
77,542
83,464
5.6%
LIABILITIES
Current Liabilities
32Accounts payable
1,392
1,485
1,510
1,495
1,514
2,049
2,569
1,856
1,766
1,753
1,844
2.9%
33Short-term debt
845.2
2,595
194.7
51.8
370.2
200
215
758
1,875
678
2
(45.4)%
34Other current liabilities
3,933
2,794
3,088
3,294
3,048
5,153
5,356
5,775
4,633
4,367
4,961
2.4%
35Total Current Liabilities
6,170
6,874
4,792
4,842
4,932
7,402
8,140
8,389
8,274
6,798
6,807
1%
Non-Current Liabilities
36Long-term debt
12,025
9,689
10,327
9,689
22,169
21,978
23,057
19,858
17,661
16,468
18,416
4.4%
37Other non-current liabilities
6,263
5,655
5,161
5,076
4,698
7,004
6,810
6,013
5,063
4,726
5,707
(0.9)%
38Total Non-Current Liabilities
18,288
15,345
15,489
14,764
26,868
28,982
29,867
25,871
22,724
21,194
24,123
2.8%
39Total Liabilities
24,458
22,219
20,281
19,606
31,800
36,384
38,007
34,260
30,998
27,992
30,930
2.4%
SHAREHOLDERS` EQUITY
40Common stock
8
8.1
8.1
8.2
8.4
9
9
9
9
9
9
1.2%
41Retained earnings / (deficit)
21,012
20,704
22,806
25,163
24,166
27,159
32,827
39,205
41,074
44,188
46,891
8.4%
42Accumulated other comprehensive income / (loss)
(2,311)
(3,022)
(1,994)
(2,791)
(3,068)
(368)
(1,027)
(2,872)
(1,748)
(3,218)
(207)
(21.4)%
43Noncontrolling interests
73.7
74
9.6
12.3
11.3
11
10
8
4
7
7
(21)%
44Total shareholders' equity
23,764
23,077
26,368
28,227
30,282
39,777
45,177
50,090
53,490
49,550
52,541
8.3%
45Total Liabilities and shareholders' Equity
48,222
45,295
46,649
47,833
62,082
76,161
83,184
84,350
84,488
77,542
83,464
5.6%
46Total Debt
12,870
12,269
10,522
9,740
22,526
22,178
23,272
20,616
19,536
17,146
18,418
3.7%
47Net Debt
12,080
11,305
9,892
8,953
2,614
16,143
20,686
14,621
13,672
15,068
13,803
1.3%
CASH FLOW STATEMENT
CASH FLOWS FROM OPERATING ACTIVITIES
48Net income (loss)
2,597
2,554
2,492
2,651
2,557
3,646
6,433
7,209
4,764
3,899
3,614
3.4%
49Depreciation & amortization
880.8
1,128
1,238
1,178
1,190
1,775
2,168
2,132
2,166
2,352
2,447
10.8%
50Share-based compensation expense
139
129.8
139.4
151.4
158.8
187
184
295
306
288
298
7.9%
51Changes in working capital and other assets
185.1
(289.8)
(392)
41.7
46.1
600
(427)
(1,117)
(72)
149
57
(11.1)%
52Net cash flows from operating activities
3,802
3,522
3,478
4,022
3,952
6,208
8,358
8,519
7,164
6,688
6,416
5.4%
CASH FLOWS FROM INVESTING ACTIVITIES
53Purchases of property, plant and equipment
(512.9)
(589.6)
(570.7)
(584)
(635.5)
(791)
(1,294)
(1,152)
(1,383)
(1,392)
(1,156)
8.5%
54Purchases of investments / marketable securities
(87.1)
4,615
247.9
(148.9)
(241)
(342)
(934)
(523)
(172)
(331)
(127)
3.8%
55Proceeds from maturities of marketable securities
43
264.8
137.9
22.2
(59.2)
13
126
18
61
253
12
(12)%
56Other investing activities
(14,394)
(9,534)
(658.5)
(2,238)
(302.4)
(20,119)
(10,885)
(577)
(5,587)
(511)
75
-
57Net cash flows from investing activities
(14,951)
(5,243)
(843.4)
(2,949)
(1,238)
(21,239)
(12,987)
(2,234)
(7,081)
(1,981)
(1,196)
(22.3)%
CASH FLOWS FROM FINANCING ACTIVITIES
58Issuance (repurchases) of common stock, net
249
164.5
68.8
96
2,216
1,882
86
31
68
(5,817)
(3,003)
-
59Dividends paid, net
(354.1)
(399.8)
(378.3)
(433.4)
(526.7)
(615)
(742)
(818)
(821)
(768)
(878)
9.5%
60Debt issuance (repayments), net
9,159
2,790
(2,665)
(442)
13,350
(1,900)
1,967
(1,688)
(1,626)
(1,669)
1,045
(19.5)%
61Other financing activities
(3.3)
(512.3)
(124.2)
(17.6)
1,327
1,639
(16)
(95)
2,106
(131)
(125)
43.8%
62Net cash flows from financing activities
9,050
2,043
(3,099)
(797)
16,366
1,006
1,295
(2,570)
(273)
(8,385)
(2,961)
-
63Increase (decrease) in cash and cash equivalents
(2,215)
172.9
(333.4)
157.7
19,125
(13,877)
(3,449)
3,409
(131)
(3,786)
2,537
-
64Cash and equivalents, ending balance
790.8
963.7
630.3
788
19,912
6,035
2,586
5,995
5,864
2,078
4,615
19.3%
65Free Cash Flow to the Firm (FCFF)
Help
Free Cash Flow to the Firm = Cash Flows from Operating Activities - Capital Expenditures
3,289
2,932
2,907
3,438
3,316
5,417
7,064
7,367
5,781
5,296
5,260
4.8%

Annual Reports, Presentations And IR Contacts

Go to the website
Annual report links (10K)
2025202420232022202120202019201820172016

Danaher Corp (DHR) financial statements and performance

Explore Danaher Corp (DHR) annual and quarterly financial statements, including revenue, operating income, net income, cash flow, assets, liabilities, and per-share metrics.

Compare reporting periods and financial trends to evaluate profitability, balance-sheet strength, cash generation, and long-term business performance.